{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:22Z","timestamp":1787021302621,"version":"build-2736575974"},"reference-count":12,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gliclazide, a second-generation sulfonylurea, is frequently utilized for glycemic management in type 2 diabetes mellitus (T2DM), attributed to its cardiovascular safety profile and minimal hypoglycemia risk. Sulfonylurea-induced bradycardia is a rare and underreported phenomenon. A 68-year-old male with a long history of T2DM and hypertension presented with presyncope, lethargy, and dizziness 10 days following the initiation of modified-release gliclazide at a dosage of 60\u2005mg once daily. Upon evaluation, the heart rate was recorded at 42 beats per minute with a regular rhythm. Electrocardiogram indicated sinus bradycardia accompanied by intermittent junctional escape beats. Echocardiography, cardiac biomarkers, thyroid function tests, and electrolyte levels were within normal limits. Twenty-four-hour Holter monitoring revealed sinus bradycardia with pauses lasting up to 3.2\u2005seconds. No evidence was found of underlying conduction abnormalities or concurrent use of other bradycardia-inducing medications. A diagnosis of bradycardia induced by gliclazide was established based on the temporal correlation and the resolution of symptoms following the discontinuation of the medication. After a modification in his antidiabetic treatment, the patient continued to exhibit no symptoms. This case underscores the necessity of identifying rare yet significant cardiac adverse effects associated with gliclazide, particularly in elderly patients, to facilitate prompt intervention and prevent unwarranted investigations.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag161","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:03:02Z","timestamp":1783904582000},"source":"Crossref","is-referenced-by-count":1,"title":["A rare case of gliclazide-induced symptomatic bradycardia in type 2 diabetes mellitus"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7612-6472","authenticated-orcid":false,"given":"Amit","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Medicine, Maulana Azad Medical College and Lok Nayak Hospital , New Delhi 110002 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maulana Azad Medical College and Lok Nayak Hospital , New Delhi 110002 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Bharti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maulana Azad Medical College and Lok Nayak Hospital , New Delhi 110002 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhvika","family":"Zutshi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maulana Azad Medical College and Lok Nayak Hospital , New Delhi 110002 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Ambedare","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maulana Azad Medical College and Lok Nayak Hospital , New Delhi 110002 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedprakash","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maulana Azad Medical College and Lok Nayak Hospital , New Delhi 110002 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"3","key":"2026071221004274900_luag161-B1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/2230-8210.149925","article-title":"Sulfonylureas: assets in the past, present and future","volume":"19","author":"Kalra","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"issue":"8","key":"2026071221004274900_luag161-B2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2362.2004.01381.x","article-title":"GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients","volume":"34","author":"Schernthaner","year":"2004","journal-title":"Eur J Clin Invest"},{"issue":"24","key":"2026071221004274900_luag161-B3","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"ADVANCE Collaborative Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"2026071221004274900_luag161-B4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrendo.2013.166","article-title":"K(ATP) channels and islet hormone secretion: new insights and controversies","volume":"9","author":"Ashcroft","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2026071221004274900_luag161-B5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6107(02)00053-6","article-title":"Physiological and pathophysiological roles of ATP-sensitive K+ channels","volume":"81","author":"Seino","year":"2003","journal-title":"Prog Biophys Mol Biol"},{"issue":"3","key":"2026071221004274900_luag161-B6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0149-2918(03)80109-1","article-title":"Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience","volume":"25","author":"Massi-Benedetti","year":"2003","journal-title":"Clin Ther"},{"key":"2026071221004274900_luag161-B7","first-page":"67","article-title":"Glibenclamide induced sinus bradycardia in a diabetic patient","volume":"60","author":"Singh","year":"2012","journal-title":"J Assoc Physicians India"},{"issue":"10","key":"2026071221004274900_luag161-B8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/106002809002401014","article-title":"Detecting drug interactions: a review of the literature","volume":"24","author":"Jankel","year":"1990","journal-title":"DICP"},{"issue":"1","key":"2026071221004274900_luag161-B9","first-page":"1","article-title":"The KATP channel and its role in regulating vascular tone","volume":"33","author":"Quayle","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2026071221004274900_luag161-B10","first-page":"164","article-title":"Autonomic and cardiovascular effects of anti-diabetic medications","volume":"3","author":"Masaki","year":"2007","journal-title":"Curr Diab Rev"},{"issue":"5","key":"2026071221004274900_luag161-B11","first-page":"569","article-title":"Glimepiride-induced bradycardia in an elderly diabetic patient","volume":"23","author":"Mizuno","year":"2006","journal-title":"Diabet Med"},{"issue":"4","key":"2026071221004274900_luag161-B12","article-title":"The association between sulfonylurea use and all-cause and cardiovascular mortality: a meta-analysis with trial sequential analysis of randomized clinical trials","volume":"13","author":"Varvaki Rados","year":"2016","journal-title":"PLoS Med"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/8\/luag161\/68761993\/luag161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/8\/luag161\/68761993\/luag161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:03:04Z","timestamp":1783904584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag161\/8732972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag161","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,2]]},"article-number":"luag161"}}